Commercialization: Page 117
-
PharmaVoice Team/PharmaVoice
Talent Pool
executive appointments and promotions in the healthcare industry Pharma POOL Robert Boisclair Dr. Richard Bowles Steve Chellevold Mary-Frances Faraji Brent Saunders Schering-Plough Announces Senior-Level Management Changes Schering-Plough, Kenilworth, N.J., has made senior-level management change...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
talent pool executive appointments and promotions in the healthcare industry Pharma POOL Robert Bertolini Schering-Plough Appoints Executive VP, Chief Financial Officer Schering-Plough has appointed Robert J. Bertolini as executive VP and chief financial officer. He also serves on the Schering-Pl...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The PC Approach to Improving the Detail
The Tablet PC is starting to gain more traction in the pharmaceutical industry, particularly as a tool for sales reps during a detail. While concerns over price, size, and user-friendliness remain, industry experts predict their use will continue to increase.ime is not on their side. Pharmaceutic...
By Lisa Dress • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Relationship building As a veteran public-relations professional, long-time volunteer, and current member of the American Cancer Society (ACS), Eastern Division Board, serving New York and New Jersey, I would like to comment on Roger Sullivan’s letter (published in October 2004) in response to th...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
What’s on your mind opinions Preferred-provider status Increasingly, companies that provide services to the life-sciences industry are required to be on a preferred provider list. In the November issue of PharmaVOICE, we asked are innovative/new ideas being overlooked in some cases because a serv...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
December 2003 Contents 8 Cyndi Verst-Brasch says Phase IV trials have to withstand regulatory vigor. 20 Pharma is becoming more involved in choosing investigator sites, says Mark Eisenach. 32 For Dr. John Patton, the life sciences are awe inspiring. on the cover The value of Phase IV Postmarketin...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
New healthcare-related products, services, and companies DVC Healthcare Launches Relationship- Marketing Practice DVC HealthCare, a division of DVC Worldwide, has expanded its service offerings to include a comprehensive relationship-marketing solution. The tool expands DVC’s ability to focus on ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
letter from the editor Phase IV studies can help differentiate a product from its competitors, medically support marketing objectives and messages, develop and enhance relationships with clinical investigators and key opinion leaders, increase physician exposure to a new drug, answer scientific q...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
The use of humor in pharmaceutical advertising, whether it is a professional or direct-to-consumer campaign, requires a delicate balance. But if done properly and with sensitivity, a light-hearted approach can separate the generic from the exceptional. Ted Whitby, senior VP and creative director ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaCase
Making a case for transformational product marketing Lena Chow Lena Chow, founder of Lena Chow Advertising, and former chairman, chief strategic officer of Euro RSCG Life, discusses the challenges of implementing successful marketing campaigns for transformational products. A New Generation of He...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Today the pharmaceutical industry faces the challenge of deploying products in an increasingly competitive and cut-throat environment. As a result, there is enormous pressure to achieve maximum return on investment before patents expire. In addition, as patents on mega-blockbusters expire, the ph...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
December 2003 The forum for the industry executive PHASE IV TRIALS Balancing marketing and science adventuring forth with John Patton Marketing to nps and pas Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
NPs and PAs: A Growing Sphere of Influence
By Elisabeth Pena Sales reps are coming to us and providing us with good educational information, as well as the latest research data. Mary Kay Tucker The number of nurse practitioners and physician assistants empowered with the authority to prescribe medication is increasing annually. Addressing...
By Elisabeth Pena • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
John Patton: A Lifetime of Adventure
by Kim Ribbink A Lifetime of Adventure With a number of ground- breaking technologies under its belt, Nektar Therapeutics is vying to be the No. 1 drug-delivery company in the world. And the company’s cofounder and chief scientific officer, John Patton, Ph.D., has led the push to unearth solution...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New electronic and web-based applications, sites, and technologies Solutions From PHT Provide Clinical Trial Savings and Flexibility Two recently launched offerings from PHT Corp., LogPad Phone and the Technology Transfer Program, aim to make the electronic capture of clinical-trial information e...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma Trax Sales, Marketing, And R&D Trends Affecting the Healthcare Industry Doctors Prefer Details by Specialty Reps In the past three years, specialty sales representatives have become an increasingly important promotional investment for pharmaceutical companies, according to VerispanĂs l...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
What can you say about a nearly 12-year-old brand that has less then half the share of the category leader and is indicated for a condition that even those who have been diagnosed have trouble paying attention to? The brand is Zocor, the asymptomatic condition is hypercholesterolemia, and the ans...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Dorothy Smith: Education, the Best Medicine
education, the best medicine Dr. Dorothy Smith has devoted her career to consumer healthcare education. She began by shaking up the role of the pharmacist by pushing for patient-counseling programs. Today, she continues to work tirelessly to ensure that consumers are informed and involved in deci...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Diagnostics and Devices: A Different Arena
Diagnostics and Devices different arena By Elisabeth Pena With smaller marketing budgets and a more focused, cost-conscious audience, the device and diagnostic sectors face challenges that require different strategies from their pharmaceutical counterparts. A number of world events bode well for ...
By Elisabeth Pena • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Data Strategy: Cracking the Marketing Code
Data Strategy Cracking the Marketing Code The creation of relevant marketing messages often relies on data that have been appropriately aggregated and analyzed. A well-conceived and implemented data strategy provides for a more targeted approach that ensures better results and increases return on...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Paul Harris Creating Memorable Visual Branding This past year, the pages of this publication and others in the pharmaceutical advertising niche have explored at length the matter of creativity in pharmaceutical ads. TheyĂve addressed such questions as: Why aren’t pharma ads more cr...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
What’s new New healthcare-related products, services, and companies The HBA – A National Brand The Healthcare BusinesswomenĂs Association has undergone a reorganization and created a new Northeast Corridor Metro Chapter to better serve its members. The Healthcare Businesswomen’s Association (HBA)...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaCase
Making a case for an Agency union A Union that Celebrates People Corbett and Accel have joined forces to form Corbett Accel Healthcare Group. The goal is to attract top talent and leverage each other’s strengths to provide the service integration required by forward-thinking clients on behalf of ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter From the Editor
Pharmaceutical manufacturers spent more in 2003 on new technology in most areas and less on maintaining existing technology than other manufacturing verticals, according to AMR Research. This is to be expected as many move to packaged or Web-based applications. Investments in databases, physical ...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Pharma trax Sales, marketing, And R&D Trends affecting the healthcare industry New Drug Commercialization Costs Lead to Blockbuster Model’s End The high cost of commercialization is leading to the demise of the pharma industry’s blockbuster approach to developing new drugs, according to a stu...
By PharmaVoice Team • Jan. 2, 2008
Previous
